Biocatalysis

Onyx Scientific Ltd, Cyprotex Discovery Ltd and Glytech, a University of York Centre for Novel Agricultural Products spin-out, have formed a unique 3-way collaboration to offer new drug metabolite identification and synthesis services to the pharmaceutical industry.
All 3 organisations contribute separate skills needed in performing this service. Onyx provides synthetic and analytical chemistry services; Cyprotex contributes in vitro screening services, metabolite profiling and identification expertise; Glytech supplies proprietary enzyme screening and bioprocessing skills providing the capability to rapidly make novel metabolite structures.

According to the companies, no single entity in the world is capable of matching this novel approach. That statement sounds a bit too strong to me, but it does add competition to a field that includes Albany Molecular Research (AMRI), Cypex, Xenotech, SPI-BIO (France) and Codexis (via BioCatalytics).